SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains)

Seattle Structural Genomics Center for Infectious Disease (SSGCID)

N-acetyl-beta-D-glucosamine; 2-acetamido-2-deoxy-beta-D-glucose; 2-acetamido-2-deoxy-D-glucose; 2-acetamido-2-deoxy-glucose; N-ACETYL-D-GLUCOSAMINE

Broad sarbecovirus neutralization by a human monoclonal antibody.

Severe acute respiratory syndrome coronavirus 2

Seattle Structural Genomics Center for Infectious Disease
NIAID, National Institute of Allergy and Infectious Diseases

National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

SARS-CoV-2, Spike glycoprotein, Fab S2X259, VIRAL PROTEIN, Structural Genomics, Seattle Structural Genomics Center for Infectious Disease, SSGCID, VIRAL PROTEIN-IMMUNE SYSTEM complex